infliximab-dyyb

FDA Drug Profile — ZYMFENTRA, INFLECTRA

infliximab-dyyb is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand names including ZYMFENTRA, INFLECTRA. Available dosage forms: kit, injection, powder, lyophilized, for solution, injection, solution, injection.

Drug details

Generic Name
infliximab-dyyb
Brand Names
ZYMFENTRA, INFLECTRA
Application Number
BLA761358
Sponsor
CELLTRION USA Inc.
NDC Codes
12
Dosage Forms
KIT, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, INJECTION, SOLUTION, INJECTION
Routes
INTRAVENOUS, SUBCUTANEOUS
Active Ingredients
INFLIXIMAB, INFLIXIMAB-DYYB

Indications and Usage

1 INDICATIONS AND USAGE ZYMFENTRA is a tumor necrosis factor (TNF) blocker indicated in adults for maintenance treatment of: moderately to severely active ulcerative colitis following treatment with an infliximab product administered intravenously. ( 1 ) moderately to severely active Crohn’s disease following with an infliximab products administered intraneously. ( 1 ) ZYMFENTRA is indicated in adults for maintenance treatment of: moderately to severely active ulcerative colitis following treatment with an infliximab product administered intravenously. moderately to severely active Crohn's disease following treatment with an infliximab product administered intravetnously.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.